Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Cameli and Laura Bergantini.
Paolo Cameli
Connection Strength
0.516
Laura Bergantini
  1. High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool? Intern Emerg Med. 2021 08; 16(5):1329-1330.
    View in: PubMed
    Score: 0.235
  2. Serial KL-6 measurements in COVID-19 patients. Intern Emerg Med. 2021 09; 16(6):1541-1545.
    View in: PubMed
    Score: 0.058
  3. Peripheral biomarkers' panel for severe COVID-19 patients. J Med Virol. 2021 03; 93(3):1230-1232.
    View in: PubMed
    Score: 0.057
  4. Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes. J Med Virol. 2021 02; 93(2):657.
    View in: PubMed
    Score: 0.056
  5. Serum KL-6 concentrations as a novel biomarker of severe COVID-19. J Med Virol. 2020 10; 92(10):2216-2220.
    View in: PubMed
    Score: 0.055
  6. Peripheral lymphocyte subset monitoring in COVID-19 Italian patients. Minerva Med. 2021 06; 112(3):423-426.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.